Product Description: BRD4-BD1-IN-2 is a selective BRD4-BD1 inhibitor, with an IC50 of 2.51 µM (20-times greater than that of BD2). BRD4-BD1-IN-2 can be used in studies of cancer and cardiovascular diseases[1].
Applications: Cancer-programmed cell death
Formula: C20H15Br3N4O2
References: [1]Chang Y, et al. Design, synthesis, biological evaluation, and molecular docking of 1, 7-dibenzyl-substituted theophylline derivatives as novel BRD4-BD1-selective inhibitors. Medicinal Chemistry Research, 2021, 30(8): 1453-1468.
CAS Number: 2761321-26-8
Molecular Weight: 583.07
Research Area: Cancer; Cardiovascular Disease
Solubility: 10 mM in DMSO
Target: Epigenetic Reader Domain